Literature DB >> 6132929

Comparative hypnotic activity of single doses of loprazolam, flurazepam, and placebo.

R Elie, G Caillé, F A Levasseur, J Gareau.   

Abstract

Loprazolam is a benzodiazepine derivative which possesses, in animals, a potent hypnotic effect. In a double-blind single-dose study, three dose levels of loprazolam (0.5, 1.0, and 2.0 mg) were compared to each other as well as to 15 mg flurazepam and placebo in 60 insomniac outpatients. The 0.5- and 1.0-mg doses demonstrated hypnotic potency comparable to that of flurazepam, and all three treatments were superior to placebo. The hypnotic effect of the 2-mg dose of loprazolam was significantly greater than that of the other treatments, but at this dose, patients experienced significantly more side effects and morning hangover.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132929     DOI: 10.1002/j.1552-4604.1983.tb02701.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Michael J Sateia; Daniel J Buysse; Andrew D Krystal; David N Neubauer; Jonathan L Heald
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

Review 2.  Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.

Authors:  B G Clark; S G Jue; G W Dawson; A Ward
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.